浏览全部资源
扫码关注微信
1.中国医学科学院北京协和医学院北京协和医院药剂科,北京 100730
2.天津中医药大学中药学院,天津 301617
3.北京大学药学院,北京 100191
4.中国医院协会药事专业委员会,北京 100035
5.首都医科大学附属北京积水潭医院药学部,北京 100035
研究方向:临床药学。E-mail:1617545147@qq.com
临床药学、药学服务。E-mail:lst19970119@163.com
研究方向:医院药学、药事管理。 E-mail:meidanpumch@163.com
纸质出版日期:2024-06-15,
收稿日期:2024-01-05,
修回日期:2024-05-20,
扫 描 看 全 文
张逸舟,都丽萍,张宇晴等.我国医疗机构用药教育开展现状调查 Δ[J].中国药房,2024,35(11):1380-1385.
ZHANG Yizhou,DU Liping,ZHANG Yuqing,et al.Investigation on the current status of medication education in medical institutions in China[J].ZHONGGUO YAOFANG,2024,35(11):1380-1385.
张逸舟,都丽萍,张宇晴等.我国医疗机构用药教育开展现状调查 Δ[J].中国药房,2024,35(11):1380-1385. DOI: 10.6039/j.issn.1001-0408.2024.11.17.
ZHANG Yizhou,DU Liping,ZHANG Yuqing,et al.Investigation on the current status of medication education in medical institutions in China[J].ZHONGGUO YAOFANG,2024,35(11):1380-1385. DOI: 10.6039/j.issn.1001-0408.2024.11.17.
目的
2
调查我国各级医疗机构用药教育开展及补偿现状,为用药教育的高质量发展提供依据和建议。
方法
2
采用网络问卷调查的方法,于2023年3月调查全国范围内各级医疗机构用药教育的开展情况,对结果进行描述性统计与影响因素分析。
结果
2
共回收问卷1 368份,其中有效问卷1 304份,问卷有效率为95.32%。我国医疗机构用药教育总体开展率为73.62%,东部、中部和西部地区用药教育开展率分别为76.05%、67.68%、73.76%,三级、二级和一级医疗机构开展率分别为87.11%、60.57%、46.32%;发药窗口是最常见的用药教育场所,口头交代是比例最高的用药教育形式。三级医疗机构与一级和二级医疗机构相比,用药教育场所和形式都更加多元;各级医疗机构总体用药教育年服务量的中位数为500人次,且医疗机构级别越高,用药教育年服务量越大(
P
=0.023);超过一半的医疗机构无任何形式的用药教育补偿,有补偿的医疗机构大多是在工作量上予以体现。医疗机构等级、信息化和自动化程度是影响用药教育是否开展的重要因素。
结论
2
与2019年相比,近年我国中部地区医疗机构用药开展率有一定提升;各地区的一级医疗机构用药教育开展率仍较低,需要继续提高。各医疗机构应根据自身特点设置用药教育场所,丰富用药教育形式,提高人才培养的数量和质量,继续积极落实药学服务收费,以促进用药教育高质量、可持续发展。
OBJECTIVE
2
To investigate the development and current status of medication education in domestic medical institutions, aiming to provide reference and suggestions for better development of medication education.
METHODS
2
The online questionnaire survey was conducted in March 2023 to investigate the implementation of medication education in medical institutions at all levels nationwide; descriptive analysis and influencing factors analysis were conducted.
RESULTS
2
A tota
l of 1 368 questionnaires were recycled, 1 304 of which were effective questionnaires, with the effective rate of 95.32%. The average rate of providing medication education was 73.62% in medical institutions nationwide, 76.05%, 67.68% and 73.76% respectively in Eastern, Central and Western regions, 87.11%, 60.57% and 46.32% respectively in tertiary, secondary and primary medical institutions. The commonest place and way of carrying out medication education were dispensing window and oral instructions, and both were more diverse in tertiary medical institutions, compared with second and primary medical institutions. The median annual service volume of medication education in medical institutions at all levels was 500 people; the higher the level of medical institutions, the larger the annual service volume of medication education (
P
=0.023). More than half of medical institutions didn’t have any form of compensation for medication education, which was mostly reflected in the workload of medical institutions with compensation. Grade of medical institutions, degree of information and automation were the major influencing factors of carrying out medication education.
CONCLUSIONS
2
The ratio of carrying out medication education is improved in the central region in China in recent years, compared with 2019; while that of primary institutions in all regions is at a low level and should be improved. The place of carrying out medication education should be set according to the characteristics of medical institutions, and medication education forms should be enriched as much as possible. The quantity and quality of medication education talents still need to be improved. Compensation for pharmaceutical care should be continually explored and implemented to prompt high-quality and sustainable development of medication education.
医疗机构用药教育影响因素补偿药学服务问卷调查
medication educationinfluencing factorscompensationpharmaceutical carequestionnaire survey
都丽萍,樊萍,金朝辉,等. 医疗机构药学服务规范:第5部分:用药教育[J]. 中国药房,2019,30(24):3315-3316,3324.
DU L P,FAN P,JIN Z H,et al. Specification for pharmaceutical care in medical institutions:part 5:drug education[J]. China Pharm,2019,30(24):3315-3316,3324.
林平,杨丽娟,邵晓楠,等. 我国用药咨询和用药教育现状调研及补偿机制探讨[J]. 中国医院,2020,24(2):12-15.
LIN P,YANG L J,SHAO X N,et al. Investigation on drug consulting and drug education and discussion on compensation mechanism in China[J]. Chin Hosp,2020,24(2):12-15.
孙雪林,张亚同,胡欣. 公众对药品使用风险的认知调查[J]. 中国药物警戒,2021,18(9):860-863.
SUN X L,ZHANG Y T,HU X. Investigation of public perceptions of drug use risks[J]. Chin J Pharmacovigil,2021,18(9):860-863.
饶兰兰,马添翼. 临床药师参与慢性心力衰竭患者慢病管理的效果评价[J]. 中国药房,2020,31(6):745-750.
RAO L L,MA T Y. Effect evaluation of clinical pharmacists participating in chronic disease management for chronic heart failure patients[J]. China Pharm,2020,31(6):745-750.
成剑锋,刘惠强,黄洁,等. 门诊药房用药教育现状及改善建议[J]. 中国医院药学杂志,2023,43(13):1512-1515.
CHENG J F,LIU H Q,HUANG J,et al. Status quo and improvement suggestions of medication education in outpatient pharmacy[J]. Chin J Hosp Pharm,2023,43(13):1512-1515.
夏宇轩,黄萍,方晴霞,等. 门诊药房多级多维用药交待体系的构建与实践[J]. 中国医院药学杂志,2022,42(15):1587-1593.
XIA Y X,HUANG P,FANG Q X,et al. Construction and practice of multi-level and multi-dimensional medication explanation system in outpatient pharmacy[J]. Chin J Hosp Pharm,2022,42(15):1587-1593.
刘皈阳,郭代红,郭绍来,等. 取消医院药品加成后医院药学工作的经济价值体现[J]. 中国药房,2007,18(31):2403-2405.
LIU G Y,GUO D H,GUO S L,et al. Economic benefits of hospital pharmaceutical services after cancelling the hospital drug price addition[J]. China Pharm,2007,18(31):2403-2405.
刘皋林,陈蓉. 新“医改” 形势下临床药师的地位和作用探讨[J]. 中国药房,2010,21(30):2785-2791.
LIU G L,CHEN R. Status and role of clinical pharmacists under new medical reform[J]. China Pharm,2010,21(30):2785-2791.
张石革,马国辉. 论药师职责转型的时代使命与其必然性[J]. 中国药房,2006,17(2):84-86.
ZHANG S G,MA G H. Responsibility transformation of pharmacists and its necessity[J]. China Pharm,2006,17(2):84-86.
海沙尔江·吾守尔,吴可,史录文. 国外部分国家(地区)药事服务补偿机制及调剂费收费方式研究[J]. 中国药房,2012,23(1):12-16.
Haishaerjiang Wushouer,WU K,SHI L W. Study on the compensation mechanisms of pharmaceutical service and charging methods of dispensing fee in several foreign countries or regions[J]. China Pharm,2012,23(1):12-16.
蔡卫民,翟晓波,何志高,等. 临床药学服务补偿机制初探[J]. 中国医院药学杂志,2011,31(1):1-4.
CAI W M,ZHAI X B,HE Z G,et al. Preliminary study on compensation mechanism of clinical pharmaceutical service[J]. Chin J Hosp Pharm,2011,31(1):1-4.
杨烁,邵晓楠,吴岢非,等. 国内外药物重整服务现状及补偿机制探讨[J]. 中国医院,2020,24(5):60-62.
YANG S,SHAO X N,WU K F,et al. Exploration of the status of domestic and foreign drug reconciliation services and compensation mechanisms[J]. Chin Hosp,2020,24(5):60-62.
杨雅麟,杨丽娟,刘思彤,等. 国内外药学查房现状及补偿机制探讨[J]. 中国医院,2020,24(2):20-23.
YANG Y L,YANG L J,LIU S T,et al. Discussion on the current situation and discussion on compensation mechanism of pharmaceutical rounds in China and abroad[J]. Chin Hosp,2020,24(2):20-23.
郑婷婷,邵晓楠,吴岢非,等. 我国医院药学门诊现状调查及对策研究[J]. 中国医院,2020,24(2):5-7.
ZHENG T T,SHAO X N,WU K F,et al. Investigation and countermeasure research on the current situation of pharmacist-managed clinics in Chinese hospitals[J]. Chin Hosp,2020,24(2):5-7.
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构